| Valproic acid | Approved Investigational | CDKN2D | 1032 |
upregulated | Valproic Acid results in increased expression of CDKN2D mRNA | 19p13.2 | |
| Valproic acid | Approved Investigational | CDKN3 | 1033 |
upregulated | Valproic Acid results in increased expression of CDKN3 mRNA | 14q22.2 | |
| Valproic acid | Approved Investigational | CDO1 | 1036 |
downregulated | Valproic Acid results in decreased expression of CDO1 mRNA | 5q22.3 | |
| Valproic acid | Approved Investigational | CDO1 | 1036 |
upregulated | Valproic Acid results in increased expression of CDO1 mRNA | 5q22.3 | |
| Valproic acid | Approved Investigational | CDON | 50937 |
upregulated | Valproic Acid results in increased expression of CDON mRNA | 11q24.2 | |
| Valproic acid | Approved Investigational | CDR2 | 1039 |
upregulated | Valproic Acid results in increased expression of CDR2 mRNA | 16p12.2 | |
| Valproic acid | Approved Investigational | CDRT4 | 284040 |
downregulated | Valproic Acid results in decreased expression of CDRT4 mRNA | 17p12 | |
| Valproic acid | Approved Investigational | CDS1 | 1040 |
upregulated | Valproic Acid results in increased expression of CDS1 mRNA | 4q21.23 | |
| Valproic acid | Approved Investigational | CDS2 | 8760 |
upregulated | Valproic Acid results in increased expression of CDS2 mRNA | 20p12.3 | |
| Valproic acid | Approved Investigational | CEACAM1 | 634 |
upregulated | Valproic Acid results in increased expression of CEACAM1 mRNA | 19q13.2 | |
| Valproic acid | Approved Investigational | CEBPA | 1050 |
upregulated | Valproic Acid results in increased expression of CEBPA mRNA | 19q13.11 | |
| Valproic acid | Approved Investigational | CEBPB | 1051 |
upregulated | Valproic Acid results in increased expression of CEBPB mRNA | 20q13.13 | |
| Valproic acid | Approved Investigational | CEBPD | 1052 |
upregulated | Valproic Acid results in increased expression of CEBPD mRNA | 8q11.21 | |
| Valproic acid | Approved Investigational | CEBPZ | 10153 |
downregulated | Valproic Acid results in decreased expression of CEBPZ mRNA | 2p22.2 | |
| Valproic acid | Approved Investigational | CECR6 | 27439 |
downregulated | Valproic Acid results in decreased expression of CECR6 mRNA | 22q11.1 | |
| Valproic acid | Approved Investigational | CELF1 | 10658 |
downregulated | Valproic Acid results in decreased expression of CELF1 mRNA | 11p11.2 | |
| Valproic acid | Approved Investigational | CELF2 | 10659 |
upregulated | Valproic Acid results in increased expression of CELF2 mRNA | 10p14 | |
| Valproic acid | Approved Investigational | CELF4 | 56853 |
upregulated | Valproic Acid results in increased expression of CELF4 mRNA | 18q12.2 | |
| Valproic acid | Approved Investigational | CELF5 | 60680 |
upregulated | Valproic Acid results in increased expression of CELF5 mRNA | 19p13.3 | |
| Valproic acid | Approved Investigational | CELF6 | 60677 |
downregulated | Valproic Acid results in decreased expression of CELF6 mRNA | 15q23 | |
| Valproic acid | Approved Investigational | CELSR1 | 9620 |
upregulated | Valproic Acid results in increased expression of CELSR1 mRNA | 22q13.31 | |
| Valproic acid | Approved Investigational | CELSR2 | 1952 |
downregulated | Valproic Acid results in decreased expression of CELSR2 mRNA | 1p13.3 | |
| Valproic acid | Approved Investigational | CELSR2 | 1952 |
upregulated | Valproic Acid results in increased expression of CELSR2 mRNA | 1p13.3 | |
| Valproic acid | Approved Investigational | CELSR3 | 1951 |
upregulated | Valproic Acid results in increased expression of CELSR3 mRNA | 3p21.31 | |
| Valproic acid | Approved Investigational | CENPBD1 | 92806 |
upregulated | Valproic Acid results in increased expression of CENPBD1 mRNA | 16q24.3 | |